Buy & Sell Linde PLC (LIN) – Linde PLC Price Today
Aura AI Summary
Key Stats
- $228.33BMarket Cap
- Basic MaterialsSector
- -6.16%3M Drawdown
- $250.69BEnterprise Value
- 1.3%Dividend Yield
- 86% Buy | 14% SellTrading Activity
- 82 daysTypical Hold Time
Linde PLC (LIN) is currently valued at a market capitalization of $228.33B, with an enterprise value of $250.69B. Over the past 52 weeks, Linde PLC has traded between a low of $389.38 and a high of $510.75, highlighting its annual price range. Over the past three months, Linde PLC has recorded a drawdown of -6.16%, reflecting recent price volatility. Linde PLC offers a dividend yield of 1.3%, with the most recent dividend of $1.60 paid on 11 Mar 26. On average, investors hold Linde PLC for approximately 82 days, indicating typical investor behavior on the platform.
About Linde PLC
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Most Recent News
Wrap Technologies to showcase non-lethal BolaWrap system at European law enforcement event in Italy
Wrap Technologies will present its non-lethal BolaWrap device, immersive WrapReality training, and policy strategies at a European law enforcement conference in Italy on May 13-14, 2026. The event aims to introduce safer, modern public safety tools t...
FDA agrees on two clearance pathways for BioCardia's Helix delivery catheter, favoring simultaneous CardiAMP therapy approval.
BioCardia announced that the FDA agreed on two possible marketing clearance pathways for its Helix Transendocardial Delivery Catheter System, with no safety or performance concerns raised. The FDA's preferred approval route is simultaneous with the C...
US Treasury may borrow over $2 trillion in fiscal 2026 amid rising debt and costs.
The US Treasury plans to borrow more than $2 trillion from private markets in fiscal year 2026, driven by a projected $2.065 trillion deficit and rising national debt nearing $39 trillion. Borrowing needs are expected to stay above $2 trillion throug...
